New drug combination shows promise for treating breast cancer
There’s promising news in the fight against breast cancer.
A new study finds combination chemotherapy medication might help shrink cancerous tumors and stop their progression.
It found that when two cancer drugs -- Herceptin and Tykerb -- join forces -- they significantly reduce breast-cancer tumor size.
They are medications typically given to women with inoperable tumors.
Researched showed tumors treated with combination treatment before surgery--were 20-percent smaller after just six-weeks.
Would you like to contribute to this story? Join the discussion.